Inflammatory Breast Cancer News and Research

RSS
Inflammatory breast cancer is a form of breast cancer that leads to inflammation and swelling of the lymphatic channels of the breast. Rather than forming a lump, cancer cells grow along the inside of the lymph vessels in the breast skin and obstruct them.
Novel drug seems to increase effectiveness of usual chemotherapy against IBC

Novel drug seems to increase effectiveness of usual chemotherapy against IBC

Quantum dots can rapidly deliver calcitriol to targeted tumor sites for treatment of IBC

Quantum dots can rapidly deliver calcitriol to targeted tumor sites for treatment of IBC

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

18F-FDG PET/CT may become important distant staging modality in patients with breast cancer

18F-FDG PET/CT may become important distant staging modality in patients with breast cancer

New 3D culture system mimics environment surrounding inflammatory breast cancer cells

New 3D culture system mimics environment surrounding inflammatory breast cancer cells

Statins improves progression-free survival in patients with inflammatory breast cancer

Statins improves progression-free survival in patients with inflammatory breast cancer

Bio-Path to initiate BP-100-1.01 Phase I trial for treatment of two types of breast cancer

Bio-Path to initiate BP-100-1.01 Phase I trial for treatment of two types of breast cancer

Tumor count in the breast an important consideration for providing radiation therapy

Tumor count in the breast an important consideration for providing radiation therapy

Ampio announces advancement of NCE001 to preclinical development

Ampio announces advancement of NCE001 to preclinical development

Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory breast cancer

Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory breast cancer

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

New cell and animal model of IBC

New cell and animal model of IBC

Synta's ganetespib shows potent in vitro and in vivo activity against multiple breast cancer types

Synta's ganetespib shows potent in vitro and in vivo activity against multiple breast cancer types

Patients having stray tumor cells in the blood should receive aggressive treatment

Patients having stray tumor cells in the blood should receive aggressive treatment

Women with inflammatory breast cancer now have a chance of treatment

Women with inflammatory breast cancer now have a chance of treatment

Amplification of ALK gene may drive rapid breast cancer metastasis

Amplification of ALK gene may drive rapid breast cancer metastasis

IBCRF awards TGen $50,000 to discover genetic origins of inflammatory breast cancer

IBCRF awards TGen $50,000 to discover genetic origins of inflammatory breast cancer

Boehringer Ingelheim initiates two afatinib phase II studies in HER2-positive breast cancer

Boehringer Ingelheim initiates two afatinib phase II studies in HER2-positive breast cancer

Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102nd AACR

Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102nd AACR

Response Genetics presents two gene expression analysis for personalized cancer tharapy selection

Response Genetics presents two gene expression analysis for personalized cancer tharapy selection